TIME, which is composed of multiple infiltrating immune cells such as tumor‐associated macrophages (TAMs), regulatory T cells (Tregs), natural killer cells, CD8+ T lymphocytes, and myeloid‐derived suppressor cells (MDSCs), modulates the efficacy of ICB.5, 6. The gene discussed is CD8A; the disease is neoplasm.